Follow
Kelly R. Rhodes
Kelly R. Rhodes
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Noninvasive targeted transcranial neuromodulation via focused ultrasound gated drug release from nanoemulsions
RD Airan, RA Meyer, NPK Ellens, KR Rhodes, K Farahani, MG Pomper, ...
Nano letters 17 (2), 652-659, 2017
1972017
Poly (beta-amino ester) s as gene delivery vehicles: challenges and opportunities
J Karlsson, KR Rhodes, JJ Green, SY Tzeng
Expert opinion on drug delivery 17 (10), 1395-1410, 2020
1202020
Polymeric micro-and nanoparticles for immune modulation
E Ben-Akiva, SE Witte, RA Meyer, KR Rhodes, JJ Green
Biomaterials science 7 (1), 14-30, 2019
852019
Development of a 3D printed, bioengineered placenta model to evaluate the role of trophoblast migration in preeclampsia
CY Kuo, A Eranki, JK Placone, KR Rhodes, H Aranda-Espinoza, ...
ACS Biomaterials Science & Engineering 2 (10), 1817-1826, 2016
832016
Nanoscale artificial antigen presenting cells for cancer immunotherapy
KR Rhodes, JJ Green
Molecular immunology 98, 13-18, 2018
762018
In situ genetic engineering of tumors for long-lasting and systemic immunotherapy
SY Tzeng, KK Patel, DR Wilson, RA Meyer, KR Rhodes, JJ Green
Proceedings of the National Academy of Sciences 117 (8), 4043-4052, 2020
522020
Biodegradable cationic polymer blends for fabrication of enhanced artificial antigen presenting cells to treat melanoma
KR Rhodes, A Isser, JW Hickey, E Ben-Akiva, RA Meyer, AK Kosmides, ...
ACS applied materials & interfaces 13 (7), 7913-7923, 2021
282021
Biomimetic tolerogenic artificial antigen presenting cells for regulatory T cell induction
KR Rhodes, RA Meyer, J Wang, SY Tzeng, JJ Green
Acta biomaterialia 112, 136-148, 2020
282020
Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis
KR Rhodes, SY Tzeng, M Iglesias, D Lee, K Storm, SY Neshat, ...
Science Advances 9 (22), eadd8693, 2023
212023
Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy
E Ben-Akiva, JW Hickey, RA Meyer, A Isser, SR Shannon, NK Livingston, ...
Acta biomaterialia 160, 187-197, 2023
192023
Wear particles derived from metal hip implants induce the generation of multinucleated giant cells in a 3-dimensional peripheral tissue-equivalent model
DK Dutta, PA Potnis, K Rhodes, SC Wood
Plos one 10 (4), e0124389, 2015
82015
Fabrication of anisotropic polymeric artificial antigen presenting cells for CD8+ T cell activation
E Ben-Akiva, KR Rhodes, RA Meyer, JJ Green
Journal of Visualized Experiments: JoVE, 58332, 2018
72018
Improvement of islet engrafts via Treg induction using immunomodulating polymeric tolerogenic microparticles
SY Neshat, SJ Bauer, KR Rhodes, VM Quiroz, VW Wong, SM Lowmaster, ...
ACS Biomaterials Science & Engineering 9 (6), 3522-3534, 2023
62023
Development of a 3D Printed, Bioengineered Placenta Model to Evaluate the Role of Trophoblast Migration in Preeclampsia. ACS Biomaterials Science & Engineering. 2016
CY Kuo, A Eranki, JK Placone, KR Rhodes, H Aranda-Espinoza, ...
62016
In silico prediction of Ebola Zaire GP1,2 immuno-dominant epitopes for the Balb/c mouse
DK Dutta, K Rhodes, SC Wood
BMC immunology 16, 1-10, 2015
52015
PLoS One
DK Dutta, PA Potnis, K Rhodes, SC Wood
32014
Tolerogenic artificial antigen-presenting cells
JJ Green, SY Tzeng, K Rhodes, G Raimondi, MI Lozano, J Spangler, ...
US Patent 12,151,000, 2024
12024
Tolerogenic Artificial Antigen Presenting Cells for Selective Tolerance in Autoimmune Disease
G Raimondi, K Rhodes, S Tzeng, MI Lozano, D VanDyke, S Neshat, ...
The Journal of Immunology 208 (1_Supplement), 60.18-60.18, 2022
12022
Automated Bioprinting of Customized Tissue Engineered Grafts for Tympanic Membrane Perforation Repair
C Kuo, E Wilson, K Rhodes, A Fuson, J Fisher, K Cleary, B Reilly
TISSUE ENGINEERING PART A 22, S29-S29, 2016
12016
Polymeric nanoparticle genetic vaccines
JJ Green, E Ben-Akiva, J Karlsson, SY Tzeng, K Rhodes, SY Neshat
US Patent App. 18/693,984, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20